BONESUPPORT CEO to present at the Medtech Showcase 2017, in conjunction with the 9th Annual Biotech Showcase™

23rd September 2020

BONESUPPORT™ Extends U.S. Distribution Agreement for CERAMENT®|BONE VOID FILLER

23rd September 2020

BONESUPPORT™ Founder Lars Lidgren Receives the 2017 OREF Clinical Research Kappa Delta Award

23rd September 2020

BONESUPPORT™ appoints Michael Diefenbeck as Chief Medical Officer

23rd September 2020

Lennart Johansson to join BONESUPPORT™ Board of Directors

23rd September 2020

BONESUPPORT™ Announces First Patient Enrolled in FORTIFY Trial with CERAMENT®|G, a novel injectable, antibiotic-eluting bone graft substitute

23rd September 2020

Final price in BONESUPPORT™’s initial public offering set at SEK 29 per share – trading on Nasdaq Stockholm commences today

23rd September 2020

Stabilization notice

23rd September 2020

BONESUPPORT™ – Pipeline Project Targeting Bioceramics Capable of Enhancing Bone Growth Awarded SEK 8 million Grant from Vinnova Sweden

23rd September 2020

Stabilization notice

23rd September 2020